Safeguarding patients in clinical trials with high mortality rates

Am J Respir Crit Care Med. 2001 Jul 15;164(2):190-2. doi: 10.1164/ajrccm.164.2.2011028.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aspirin / analogs & derivatives
  • Aspirin / therapeutic use
  • Blood Substitutes / therapeutic use
  • Clinical Trials as Topic / standards*
  • Critical Illness / mortality*
  • Critical Illness / therapy*
  • Hemoglobins / therapeutic use
  • Human Growth Hormone / therapeutic use
  • Humans
  • Shock, Hemorrhagic / drug therapy
  • Shock, Septic / drug therapy
  • omega-N-Methylarginine / therapeutic use

Substances

  • Blood Substitutes
  • Hemoglobins
  • Human Growth Hormone
  • omega-N-Methylarginine
  • diaspirin-cross-linked hemoglobin
  • Aspirin